CN109394824A - A kind of anaesthetic of bone-setting pain stopping and preparation method thereof - Google Patents
A kind of anaesthetic of bone-setting pain stopping and preparation method thereof Download PDFInfo
- Publication number
- CN109394824A CN109394824A CN201811562621.3A CN201811562621A CN109394824A CN 109394824 A CN109394824 A CN 109394824A CN 201811562621 A CN201811562621 A CN 201811562621A CN 109394824 A CN109394824 A CN 109394824A
- Authority
- CN
- China
- Prior art keywords
- parts
- substituted
- bone
- anaesthetic
- rheum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 60
- 208000002193 Pain Diseases 0.000 title claims abstract description 45
- 230000036407 pain Effects 0.000 title claims abstract description 45
- 230000003444 anaesthetic effect Effects 0.000 title claims abstract description 43
- 239000003814 drug Substances 0.000 claims abstract description 116
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 93
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 85
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims abstract description 47
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 45
- 239000004471 Glycine Substances 0.000 claims abstract description 42
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims abstract description 40
- 235000004279 alanine Nutrition 0.000 claims abstract description 39
- 239000002994 raw material Substances 0.000 claims abstract description 39
- 239000000126 substance Substances 0.000 claims abstract description 37
- 239000010282 Emodin Substances 0.000 claims abstract description 36
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 claims abstract description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 102
- 240000004980 Rheum officinale Species 0.000 claims description 89
- 235000008081 Rheum officinale Nutrition 0.000 claims description 89
- 235000019441 ethanol Nutrition 0.000 claims description 52
- 239000011049 pearl Substances 0.000 claims description 51
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 38
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 37
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 37
- 244000020518 Carthamus tinctorius Species 0.000 claims description 37
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 37
- 229940116229 borneol Drugs 0.000 claims description 37
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 37
- 241001412627 Adenophora liliifolia Species 0.000 claims description 34
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 34
- 241000180649 Panax notoginseng Species 0.000 claims description 33
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 33
- 239000002023 wood Substances 0.000 claims description 30
- 244000248162 Xanthoceras sorbifolium Species 0.000 claims description 29
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 27
- 239000006187 pill Substances 0.000 claims description 23
- 239000000706 filtrate Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 18
- 239000008280 blood Substances 0.000 claims description 16
- 210000004369 blood Anatomy 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 14
- 241000283707 Capra Species 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 10
- 240000003705 Senecio vulgaris Species 0.000 claims description 8
- 230000009194 climbing Effects 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- FYHXNYLLNIKZMR-UHFFFAOYSA-N calcium;carbonic acid Chemical compound [Ca].OC(O)=O FYHXNYLLNIKZMR-UHFFFAOYSA-N 0.000 claims 1
- 239000002024 ethyl acetate extract Substances 0.000 claims 1
- 208000010392 Bone Fractures Diseases 0.000 abstract description 73
- 229940079593 drug Drugs 0.000 abstract description 54
- 230000000694 effects Effects 0.000 abstract description 37
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 30
- 201000010099 disease Diseases 0.000 abstract description 29
- 230000000857 drug effect Effects 0.000 abstract description 15
- 231100000331 toxic Toxicity 0.000 abstract description 14
- 230000002588 toxic effect Effects 0.000 abstract description 14
- 230000008961 swelling Effects 0.000 abstract description 12
- 208000027418 Wounds and injury Diseases 0.000 abstract description 11
- 206010052428 Wound Diseases 0.000 abstract description 10
- 208000026137 Soft tissue injury Diseases 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 206010017076 Fracture Diseases 0.000 description 45
- 235000010216 calcium carbonate Nutrition 0.000 description 35
- 238000003745 diagnosis Methods 0.000 description 31
- 230000008859 change Effects 0.000 description 25
- 238000004458 analytical method Methods 0.000 description 24
- 238000002474 experimental method Methods 0.000 description 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- 239000004615 ingredient Substances 0.000 description 20
- 208000027502 Ankle fracture Diseases 0.000 description 18
- 238000004364 calculation method Methods 0.000 description 18
- 210000002303 tibia Anatomy 0.000 description 18
- 238000006467 substitution reaction Methods 0.000 description 17
- 230000001225 therapeutic effect Effects 0.000 description 15
- 210000000988 bone and bone Anatomy 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 12
- 239000000463 material Substances 0.000 description 11
- 230000035876 healing Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 230000029663 wound healing Effects 0.000 description 10
- 208000008924 Femoral Fractures Diseases 0.000 description 9
- 230000004221 bone function Effects 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 238000011084 recovery Methods 0.000 description 9
- 238000003810 ethyl acetate extraction Methods 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000000144 pharmacologic effect Effects 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 7
- 230000003247 decreasing effect Effects 0.000 description 7
- 238000011835 investigation Methods 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- 238000003672 processing method Methods 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 6
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 238000005457 optimization Methods 0.000 description 6
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 6
- 229950005143 sitosterol Drugs 0.000 description 6
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 5
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 5
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 5
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 5
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 5
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 235000015500 sitosterol Nutrition 0.000 description 5
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 4
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 235000010855 food raising agent Nutrition 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 3
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 3
- 229910021532 Calcite Inorganic materials 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 description 3
- 235000019738 Limestone Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- NEEQFPMRODQIKX-REOHCLBHSA-N N(3)-oxalyl-L-2,3-diaminopropionic acid Chemical compound OC(=O)[C@@H](N)CNC(=O)C(O)=O NEEQFPMRODQIKX-REOHCLBHSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 125000004494 ethyl ester group Chemical group 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000006028 limestone Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- -1 tetrarin (Tetrarin) Substances 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 241001116477 Adenophora triphylla Species 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000382825 Cristaria plicata Species 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 241000208686 Eucommiaceae Species 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010019842 Hepatomegaly Diseases 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000588653 Neisseria Species 0.000 description 2
- BMLZFLQMBMYVHG-UHFFFAOYSA-N Phellopterin Chemical compound O1C(=O)C=CC2=C1C(OCC=C(C)C)=C1OC=CC1=C2OC BMLZFLQMBMYVHG-UHFFFAOYSA-N 0.000 description 2
- XXARIFJTXNCWNT-UHFFFAOYSA-N Phellopterin Natural products COc1c2C=CC(=O)Oc2c(OC=CC(C)C)c3occc13 XXARIFJTXNCWNT-UHFFFAOYSA-N 0.000 description 2
- 241001212699 Pinctada martensii Species 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000219061 Rheum Species 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- UZXMLGUMBQQVME-UHFFFAOYSA-N Swietenocoumarin B Natural products O1C(=O)C=CC2=C1C(CC=C(C)C)=C1OC=CC1=C2OC UZXMLGUMBQQVME-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 229960002045 bergapten Drugs 0.000 description 2
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical class NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 239000004579 marble Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 235000004400 serine Nutrition 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- DTGKSKDOIYIVQL-NQMVMOMDSA-N (+)-Borneol Natural products C1C[C@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-NQMVMOMDSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- RDIMTXDFGHNINN-UHFFFAOYSA-N (3R,9R,10R)-1-heptadecen-4,6-diyne-3,9,10-triol Natural products CCCCCCCC(O)C(O)CC#CC#CC(O)C=C RDIMTXDFGHNINN-UHFFFAOYSA-N 0.000 description 1
- BDHQMRXFDYJGII-UEBIAWITSA-N 24-methylenecycloartanol Chemical compound CC(C)([C@@H](O)CC1)[C@H]2[C@@]31C[C@@]13CC[C@]3(C)[C@@H]([C@H](C)CCC(=C)C(C)C)CC[C@@]3(C)[C@@H]1CC2 BDHQMRXFDYJGII-UEBIAWITSA-N 0.000 description 1
- KKSCKZFKHNHGEO-UHFFFAOYSA-N 24-methylenecycloartanol Natural products CC(CCC(=C)C(C)(C)O)C1CCC2C3CCC4C(C)(C)C(O)CCC45CC35CCC12C KKSCKZFKHNHGEO-UHFFFAOYSA-N 0.000 description 1
- BJZVHTWNCLKZGN-SPQNPFHSSA-N 24-methylidenecycloartanol Natural products CC(C)C(=C)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C(C)(C)[C@@H](O)CC[C@@]45C[C@@]35CC[C@]12C BJZVHTWNCLKZGN-SPQNPFHSSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241001633574 Adenophora stricta Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000432824 Asparagus densiflorus Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 241000270311 Crocodylus niloticus Species 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 240000005636 Dryobalanops aromatica Species 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010052359 Gingival abscess Diseases 0.000 description 1
- 244000146486 Glehnia littoralis Species 0.000 description 1
- 235000004036 Glehnia littoralis Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 241001113308 Jacobaea argunensis Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 206010024572 Lip ulceration Diseases 0.000 description 1
- 208000032923 Lobar pneumonia Diseases 0.000 description 1
- RCQBVCISWCRYBO-SOYDKUNTSA-N Lupenone Natural products CC(=C)[C@@H]1CC[C@]2(C)CC[C@@H]3[C@H](CC[C@H]4[C@@]3(C)CC[C@H]5C(C)(C)C(=O)CC[C@]45C)[C@@H]12 RCQBVCISWCRYBO-SOYDKUNTSA-N 0.000 description 1
- GRBHNQFQFHLCHO-UHFFFAOYSA-N Lupenonq Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C GRBHNQFQFHLCHO-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 description 1
- XCWPUUGSGHNIDZ-UHFFFAOYSA-N Oxypertine Chemical compound C1=2C=C(OC)C(OC)=CC=2NC(C)=C1CCN(CC1)CCN1C1=CC=CC=C1 XCWPUUGSGHNIDZ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 208000034510 Parotid gland inflammation Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241001464055 Pteriidae Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 241000254062 Scarabaeidae Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000452298 Sinanodonta woodiana Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000217379 Unionidae Species 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- VDIQGOWLVYFDOU-UHFFFAOYSA-H [Ca+]O.[Ca+]O.[Ca+]O.[O-]P([O-])([O-])=O Chemical compound [Ca+]O.[Ca+]O.[Ca+]O.[O-]P([O-])([O-])=O VDIQGOWLVYFDOU-UHFFFAOYSA-H 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- FPVGTPBMTFTMRT-NSKUCRDLSA-L fast yellow Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(N)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 FPVGTPBMTFTMRT-NSKUCRDLSA-L 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 235000011868 grain product Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000000971 hippocampal effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- OLOOJGVNMBJLLR-UHFFFAOYSA-N imperatorin Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OCC=C(C)C OLOOJGVNMBJLLR-UHFFFAOYSA-N 0.000 description 1
- XKVWLLRDBHAWBL-UHFFFAOYSA-N imperatorin Natural products CC(=CCOc1c2OCCc2cc3C=CC(=O)Oc13)C XKVWLLRDBHAWBL-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 235000021154 instant breakfast Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- GRBHNQFQFHLCHO-BHMAJAPKSA-N lupenone Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C GRBHNQFQFHLCHO-BHMAJAPKSA-N 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 208000027753 pain disease Diseases 0.000 description 1
- RDIMTXDFGHNINN-IKGGRYGDSA-N panaxytriol Chemical compound CCCCCCC[C@H](O)[C@@H](O)CC#CC#C[C@H](O)C=C RDIMTXDFGHNINN-IKGGRYGDSA-N 0.000 description 1
- ZCKMUKZQXWHXOF-UHFFFAOYSA-N panaxytriol Natural products CCC(C)C(C)C(C)C(C)C(C)C(O)C(O)CC#CC#CC(O)C=C ZCKMUKZQXWHXOF-UHFFFAOYSA-N 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 150000005838 radical anions Chemical class 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 150000003355 serines Chemical class 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000036228 toxication Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 208000025301 tympanitis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physical Education & Sports Medicine (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Inorganic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to a kind of drug and production method, i.e., a kind of anaesthetic of bone-setting pain stopping and preparation method thereof.Including bulk pharmaceutical chemicals Cortex Eucommiae, its main feature is that: the Cortex Eucommiae and cupreol, rheum emodin, calcium carbonate, glycine, alanine compatibility, the above-mentioned anaesthetic is prepared from the following raw materials in parts by weight: 18-22 parts of Cortex Eucommiae, 0.5-0.8 part of cupreol, 0.2-0.3 part of rheum emodin, 0.5-1 parts of calcium carbonate, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine.Beneficial effect is: giving full play to the drug effect of Cortex Eucommiae, synthetism, swelling and pain relieving effect substantially enhance, to various fracture caused by wound, the diseases such as dislocation, soft tissue injury are significant in efficacy, and have no toxic side effect, and preparation is simple, it is low in cost, it is expected to the common anaesthetic as set a broken bone.
Description
Technical field
The present invention relates to a kind of drug and production method, i.e., a kind of anaesthetic of bone-setting pain stopping and preparation method thereof.
Background technique
Fracture, is that the continuity of bone structure is broken completely or partially.Its reason mainly has direct, indirect violence, accumulation
Property strain etc..When treatment other than the measures such as reset, fixation, functional training, it is necessary to be subject to drug therapy.Common treatment bone
The drug of folding is mostly Western medicine and Chinese medicine, and there are also a small number of national drugs.The Mongols is just known as " national on the horse back " from ancient times, because
This, Mongolian medicine has novel viewpoint and unique method to the treatment of bone fracture, and forms the anaesthetic proved recipe of many treatment fracture, this
A little proved recipes are Ancient Mongolian nationality people labour experience and crystallization of wisdom, are spread always so far, almost without any change, so
And the great attention with society to traditional Mongolia Medicine with advances in technology, the study found that there is big in the proved recipe of Mongolian medicine
The invalid components or even toxic component of amount, each ingredient mix, and cause anaesthetic dosage big, slowly effective, toxic side effect
By force, inconvenient to use, inconvenience storage transport limits the development and utilization of anaesthetic.Preparation method is also mostly that medicinal material fecula is whole
It crushes, is all used as medicine, limits the efficiency of drug effective region to play a role.Cortex Eucommiae in anaesthetic is bone-setting pain stopping, treatment
The key medicine of bone fracture bone fracture disease, Cortex Eucommiae, the Mongolian great thermal map-treasured of name are eaten " errorless anaesthetic mirror ", and different name reaches cloth monk " recognizing medicine Bai Jingjian ", quick to reach
Pine-sharp sketch map-hair in sea all, Cha Gan-hair all " anaesthetic ".It is sweet in flavor from the bark of Eucommiaceae plant Cortex Eucommiae, it is mild-natured.Effect
It is greasy, rough, solid, warm, again, it is dry, there is synthetism, heat-clearing effect cures mainly fracture, and bone is warm, tendon lacerated wound etc..And form it is many with
Cortex Eucommiae is the anaesthetic prescription of the set a broken bone of monarch drug in a prescription, but in above-mentioned prescription, the taste number of medicine is more, and curative effect is not significant, and compatibility is not true
It cuts, is not accurate, non-compatibe drug or ingredient are also mixed into wherein, cause dosage big, and slowly effective, toxic side effect is strong, not housecoat
With inconvenience stores the problems such as transporting.
For these reasons, a kind of, significant in efficacy, illiteracy of the bone-setting pain stopping that has no toxic side effect accurate with Cortex Eucommiae compatibility is found
Medicine and simple and effective preparation method become Mongolia Medicine worker and compel highly necessary to solve the problems, such as.
Summary of the invention
The purpose of the present invention is find be more suitable for Cortex Eucommiae compatibility, have synthetism, analgesic, detumescence the effect of anaesthetic, and
It is significant in efficacy, it has no toxic side effect, the anaesthetic of cheap bone-setting pain stopping.
It is a further object of the present invention to provide the preparation methods of above-mentioned anaesthetic.
Above-mentioned purpose is realized by the following technical solutions: a kind of anaesthetic of bone-setting pain stopping, including bulk pharmaceutical chemicals Cortex Eucommiae are provided,
Its main feature is that: the Cortex Eucommiae and cupreol, rheum emodin, calcium carbonate, glycine, alanine compatibility, the above-mentioned anaesthetic by with
The bulk pharmaceutical chemicals of lower parts by weight are made: 18-22 parts of Cortex Eucommiae, 0.5-0.8 part of cupreol, and 0.2-0.3 part of rheum emodin, calcium carbonate
0.5-1 parts, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine.
The raw material medicaments in part by weight is added safflower 12-18 parts, 0.5-1.5 parts of borneol.
Described 0.5-0.8 part of cupreol is substituted by 12-18 portions of Radix Notoginseng, and described 0.2-0.3 part of rheum emodin by 4-6
Part rheum officinale substitution, 0.5-1 parts of the calcium carbonate, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine by 4-6 parts of pearls processed
Substitution.
0.5-0.8 part of the cupreol is substituted by 10-12 parts of wood of shiny-leaved yellowhorn, 0.2-0.3 part of the rheum emodin by
4-6 parts of rheum officinale substitutions, 0.5-1 parts of the calcium carbonate, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine is made by 4-6 parts
Pearl substitution.
Described 0.5-0.8 part of cupreol is substituted by 10-12 parts of the root of straight ladybell, and described 0.2-0.3 part of rheum emodin by 4-6
Part rheum officinale substitution, 0.5-1 parts of the calcium carbonate, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine by 4-6 parts of pearls processed
Substitution.
Described 0.5-0.8 part of cupreol is substituted by 12-18 portions of Radix Notoginseng, and described 0.2-0.3 part of rheum emodin by 4-
6 parts of rheum officinale substitutions, 0.5-1 parts of the calcium carbonate, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine by 2-4 parts of keel
Substitution.
0.5-0.8 part of the cupreol is substituted by 10-12 parts of wood of shiny-leaved yellowhorn, 0.2-0.3 part of the rheum emodin by
4-6 parts of rheum officinale substitutions, 0.5-1 parts of the calcium carbonate, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine by 2-4 parts of dragons
Bone substitution.
Described 0.5-0.8 part of cupreol is substituted by 10-12 parts of the root of straight ladybell, and described 0.2-0.3 part of rheum emodin by 4-
6 rheum officinales substitution, 0.5-1 parts of the calcium carbonate, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine is replaced by 2-4 parts of keel
Generation.
The raw material medicaments in part by weight is added 3-5 parts of climbing groundsel, 4-6 parts of blood of goats.
A kind of preparation method of the anaesthetic of the bone-setting pain stopping, it is characterised in that: above-mentioned raw materials medicine is taken by weight,
It crushes, sieves with 100 mesh sieve, mix, add water, the water-bindered pill is made.
The preparation method of the anaesthetic of a kind of bone-setting pain stopping, it is characterised in that: take above-mentioned raw materials by the parts by weight
Medicine takes Radix Notoginseng, rheum officinale, pearl processed or wood of shiny-leaved yellowhorn, rheum officinale, pearl processed or the root of straight ladybell, rheum officinale, pearl processed or Radix Notoginseng, rheum officinale, dragon
Bone or wood of shiny-leaved yellowhorn, rheum officinale, keel or the root of straight ladybell, rheum officinale, keel, are put into ether, are ultrasonically treated 40Min, and filtering discards filter
Liquid takes filter residue, is sequentially placed into ethyl acetate, 65% ethyl alcohol, in 80% ethyl alcohol, under the conditions of 40-50 DEG C, is ultrasonically treated respectively
1h, filtering, the filtrate that combined ethyl acetate extraction, 65% ethyl alcohol extraction, 80% ethyl alcohol extract are concentrated filtrate, make liquid content
It is 10% -20%, then is mixed with other bulk pharmaceutical chemicals powder, the water-bindered pill is made.
The beneficial effects of the present invention are: giving full play to the drug effect of Cortex Eucommiae, synthetism, swelling and pain relieving effect substantially enhance, externally
Various fracture caused by hurting, the diseases such as dislocation, soft tissue injury are significant in efficacy, and have no toxic side effect, and preparation is simple, low in cost,
It is expected the common anaesthetic as set a broken bone.
Specific embodiment
The first embodiment: following bulk pharmaceutical chemicals are taken by weight: 18-22 parts of Cortex Eucommiae, 0.5-0.8 part of cupreol, rheum officinale
0.2-0.3 part, 0.5-1 parts of calcium carbonate, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine of element.It is preferred that: 20 parts of Cortex Eucommiae, β-
0.65 part of sitosterol, 0.25 part of rheum emodin, 0.75 part of calcium carbonate, 0.15 part of glycine, 0.15 part of alanine.Take above-mentioned raw materials
Medicine, it may be assumed that Cortex Eucommiae, cupreol, rheum emodin, calcium carbonate, glycine, alanine crush, and mix, sieve with 100 mesh sieve, add water, be made
The water-bindered pill.
Bulk pharmaceutical chemicals analysis:
Cortex Eucommiae, the Mongolian great thermal map-treasured of name are eaten " errorless anaesthetic mirror ", and different name reaches cloth monk " recognizing medicine Bai Jingjian ", Min Dasong-Hai Lisu
Figure-hair all, Cha Gan-hair all " anaesthetic ".From the bark of Eucommiaceae plant Cortex Eucommiae, pharmacological property: it is sweet in flavor, it is mild-natured.Imitate it is greasy,
It is rough, solid, warm, again, it is dry.Major function: synthetism, heat-clearing.Cure mainly fracture, bone heat, tendon lacerated wound etc..
Cupreol, English: sitosterol, alias: beta- sitosterol, phytosterol, (3 β)-beans steroid -5- alkene -3-
Alcohol, sitosterol, sitosterol, Sitosterolum.Molecular formula C29H50O.Sterol is a kind of substance for having physiological activity, can be promoted for drug
Into wound healing, make hypertrophy, enhances capillary circulation.Sitosterol is nontoxic, non-stimulated to skin, has significant anti-inflammatory
Function can be used for treating cutaneum carcinoma and skin ulcer, and have norcholesterol, cough-relieving, eliminating the phlegm, the work for inhibiting tumour and repair tissue
With.For hypercholesterolemia, atherosclerosis and chronic bronchitis, it to be also used for pre-term cervical cancer and skin ulcer
Deng.
Rheum emodin is a kind of orange-yellow long acicular crystal,AcetoneIt is middle crystallization be it is orange, in methanol crystallization be yellow, melt
256 DEG C~257 DEG C of point, the special reaction with anthraquinone, is practically insoluble in water, is dissolved in ethyl alcohol and aqueous slkali.Clinically, with big
Flavine pure product treats cancer, is mainly used for the tumours such as leukaemia, gastric cancer, and most common, is used forIt is antibacterial.It is to many bacteriums
Such as various staphylococcuses, hemolytic streptococcus, corynebacterium diphtheriae, comma bacillus, Escherichia coli, Pseudomonas aeruginosa, dermatophyte, withered grass
The suitable bacillus of bacillus, Mycobacterium graminis, gonococcus, charcoal, grass-like bacterium, typhoid bacillus,Shigella dysenteriaeDeng there is inhibiting effect.It is wherein right
Staphylococcus, gonococcus, streptococcus are more effective.This product is also effective to fungi, virus, protozoon.Meanwhile also there is diuresis, benefit
Gallbladder, spasmolysis, reduce blood pressure the effects of inhibiting immune function.Almost each section all uses modern age clinic, such as treats encephalitis B and the parotid gland
Inflammation, typhoid fever, dysentery, urinary tract infections, stranguria syndrome, pneumonia, cellulitis, suppurative dermatosis, tympanitis, vasculitis etc. and its
He treats acute and subacute appendicitis, burn, polio, eczema and several fungus-caused skin infections by compatibility of drugs,
In addition hepatitis, pinworm, stomatitis, oral lip's ulcer, indigestion, hypertension and artery sclerosis etc. can be treated, therefore, rheum emodin exists
Clinically using extremely wide.
Calcium carbonate, Calcium carbonate, molecular formula: CaCO3.It is a kind of inorganic compound, is commonly called as: lime stone, lime
Stone, mountain flour, marble etc..Main component: calcite, chemical formula are CaCO3, it is in neutrality, is substantially insoluble in, is dissolved in salt
Acid.It is Common materials on the earth, is present in the rocks such as aragonite, calcite, chalk, limestone, marble, calcareous tufa, also
For the main component of animal skeleton or shell.Precipitated calcium carbonate can be used as leavening agent, Flour ingredient, anticaking agent, acidity adjustment
Agent, nutrition fortifier, curing agent etc..China provides the varieties of food items that can be used for that swelling agent need to be added and chewing gum base, presses
GMP.It can also be used for flour improver, maximum usage amount is 0.03%;7.5~18g/kg of milk powder;Soymilk powder, 4~20g/ of bean powder
kg;0.4~3.4g/kg of soft drink;6~8g/kg of lotus root starch;2~7g/kg of instant breakfast cereal products.FDA(184.1192,
2000) property provides with no restrictions, by GMP.Mostly be used cooperatively with other kinds when this product makees leavening agent use, with sodium bicarbonate,
The leavening agent that the compoundings such as alum obtain, heat then slowly release carbon dioxide, and food is made to generate uniform, fine and smooth bulk body,
The quality of cake, bread, biscuit can be improved.In addition there are the effect for strengthening calcium, the smaller easier absorptions of calcium carbonate granule.In day
This, precipitated calcium carbonate is used as leavening agent, and dosage is 1% in normal food.Can also be used as feed nutrition hardening agent.Calcium carbonate is to cover
The main component of medicine calcite has clear bar up to xeothermic, and antiemetic antidiarrheal, helps digestion, detoxifies, the function such as broken ruffian, callus, synthetism tune member
Effect.
Glycine, (Glycine, abridge Gly) also known as amion acetic acid, chemical formula C2H5NO2.Solid glycine is
The crystal or white crystalline powder of white monoclinic system or hexagonal crystal system, it is odorless, it is nontoxic [2];It is readily soluble in water, it is several in ether
It is insoluble.
Alanine is the basic unit for constituting protein, is one of the 20 kinds of amino acid for forming human body protein.Its point
Minor is C3H7NO2, there is two kinds of isomers of α-alanine and Beta-alanine.Medicinal: prevention kidney stone assists glucose
Metabolism helps mitigation hypoglycemia, improves body energy.
Prescription analysis: Cortex Eucommiae, synthetism, heat-clearing cure mainly fracture, and bone heat is monarch drug in a prescription, and minister promotes wound to be cured with cupreol
It closes, makes hypertrophy, enhance capillary circulation, calcium carbonate, supplement calcium is helped with rheum emodin, and anti-inflammatory makes with glycine, third
Propylhomoserin improves body energy, strengthen immunity, and said medicine complements each other, and synthetism, swelling and pain relieving effect is played altogether, to treat
To various fracture caused by wound, each disease such as dislocation, soft tissue injury.
Usage and dosage: with (in addition to auxiliary material) containing main medicine calculation, a 1.0-1.5g, 3 times a day.
With reference to " clinical disease diagnosis is according to the criteria for recovery " (second edition), the medical officer people is published, and edits Sun Chuanxing, knot
Feature of the present invention is closed, healing improvement standard of the invention is formulated.
Cure: union, bone function are wholly or substantially restored.
It improves: aligning and be fixed well, wound healing after operation, feeling of pain mitigates.
Invalid: symptom is not any change, and X-ray examination is not any change.
Since 2002, using set a broken bone patient 128 of the present invention, wherein 32 people of Patients with Bone Fracture, fracture of tibia
32 people of patient, 31 people of patellar fracture patient, 33 people of ankle fracture patient, experiment case pass through the attached doctor of National University of the Inner Mongol
Institute's diagnosis is made a definite diagnosis, and disease type, number of cases and treatment condition are as follows:
Calculation formula: cure rate=(curing number/sum) × 100%, total effective rate=(sum-invalid number)/sum ×
100%。
As it can be seen that being existed using the cure rate of present invention treatment femoral fracture, fracture of tibia, patellar fracture, ankle fracture
56.2% or more, for total effective rate 78.8% or more, average cure rate is 57.8%, and average total effective rate is 80.5%.
Second of embodiment: on the basis of the first embodiment, safflower 12-18 is added in the raw material medicaments in part by weight
Part, 0.5-1.5 parts of borneol.That is: safflower 12-18 parts, 0.5-1.5 parts of borneol.That is: Cortex Eucommiae 18-22 parts, cupreol 0.5-0.8
Part, 0.2-0.3 part of rheum emodin, 0.5-1 parts of calcium carbonate, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine, safflower 12-18
Part, 0.5-1.5 parts of borneol.It is preferred that: 20 parts of Cortex Eucommiae, 0.65 part of cupreol, 0.25 part of rheum emodin, 0.65 part of calcium carbonate, sweet ammonia
0.15 part, 0.15 part of alanine, 15 parts of safflower, 1 part of borneol of acid.Take above-mentioned raw materials medicine i.e.: Cortex Eucommiae, cupreol, rheum emodin, carbon
Sour calcium, glycine, alanine, safflower, borneol are crushed, are sieved with 100 mesh sieve, and are mixed, are added water, the water-bindered pill is made.
Newly-increased bulk pharmaceutical chemicals analysis:
Safflower, Mongolian name Gu Gu wood, E Ligeneisai mattress.For the dry flower of compositae plant safflower.This product is sweet in flavor, slight bitter, property
It is cool, again, it is blunt, soft, solid.The effect of having removing heat from the liver, invigorating blood circulation, relieve pain, menstruation regulating, reduce swelling, nourish positive essence.For hepatomegaly, hepatic injury,
Mesh is yellow, and the livers such as liver blood excess heat are newly old to take a disease;Hepatomegaly, liver function are weak.
Borneol, Mongolian name Xi Le-loud, high-pitched sound " recognize medicine Bai Jingjian " within the next few days, and different name looks into dry-loud, high-pitched sound " errorless anaesthetic mirror " within the next few days, and Lip river is all
Exhale the honest loud, high-pitched sound of gold-hair within the next few days " anaesthetic ".The native crystal chemical combination being precipitated in the resin of Spore density borneo camphor tree
Object.Pharmacological property: bitter, pungent, puckery, cold in nature.It imitates rough, light, blunt, dilute, dynamic, light, soft.Major function: heat-clearing, reduces swelling, analgesic.It cures mainly vehement
Heat, epidemic disease heat, old heat, intermal comflict heat are got mildewed in warm conditions, scorchingly hot, erysipelas, toothache, hot eyes, pharyngitis, aphthae.
Prescription analysis: in the first embodiment bulk pharmaceutical chemicals Cortex Eucommiae, cupreol, rheum emodin, calcium carbonate, glycine, the third ammonia
On the basis of acid, the effect of safflower enhances promoting blood circulation and stopping pain is added, borneol is added, clear bone heat is reduced swelling, and analgesic further increases
Strong above-mentioned prescription synthetism, swelling and pain relieving effect, so as to further treat to various fracture caused by wound, dislocation,
Each disease such as soft tissue injury.
Usage and dosage: with (in addition to auxiliary material) containing main medicine calculation, a 1.0-2.0g, 3 times a day.
With reference to " clinical disease diagnosis is according to the criteria for recovery " (second edition), the medical officer people is published, and edits Sun Chuanxing, knot
Feature of the present invention is closed, healing improvement standard of the invention is formulated.
Cure: union, bone function are wholly or substantially restored.
It improves: aligning and be fixed well, wound healing after operation, feeling of pain mitigates.
Invalid: symptom is not any change, and X-ray examination is not any change.
Since 2002, using set a broken bone patient 130 of the present invention, wherein 33 people of Patients with Bone Fracture, fracture of tibia
32 people of patient, 32 people of patellar fracture patient, 33 people of ankle fracture patient, experiment case pass through the attached doctor of National University of the Inner Mongol
Institute's diagnosis is made a definite diagnosis, and disease type, number of cases and treatment condition are as follows:
Calculation formula: cure rate=(curing number/sum) × 100%, total effective rate=(sum-invalid number)/sum ×
100%。
As it can be seen that being existed using the cure rate of present invention treatment femoral fracture, fracture of tibia, patellar fracture, ankle fracture
66.7% or more, for total effective rate 87.9% or more, average cure rate is 69.2%, and average total effective rate is 90.8%.Compared with first
The average cure rate of kind embodiment improves 11.4 percentage points, and average total effective rate improves 10.3 percentage points, has received imaginary
Less than therapeutic effect.
The third embodiment: on the basis of second of embodiment, 0.5-0.8 part of the cupreol by
12-18 parts of Radix Notoginseng substitutions, described 0.2-0.3 part of rheum emodin is substituted by 4-6 parts of rheum officinales, and 0.5-1 parts of the calcium carbonate is sweet
0.1-0.2 part of propylhomoserin, 0.1-0.2 part of alanine is substituted by 4-6 parts of pearls processed.That is: Cortex Eucommiae 18-22 parts, 12-18 parts of Radix Notoginseng,
4-6 parts of rheum officinale, pearl 4-6 parts processed, 12-18 parts of safflower, 0.5-1.5 parts of borneol.It is preferred that: 20 parts of Cortex Eucommiae, 15 parts of Radix Notoginseng, rheum officinale 5
Part, 5 parts of pearl processed, 15 parts of safflower, 1 part of borneol.
Preparation method one: above-mentioned raw materials medicine is taken by weight, it may be assumed that Cortex Eucommiae, Radix Notoginseng, rheum officinale, pearl processed, safflower, borneol, powder
It is broken, it sieves with 100 mesh sieve, adds water, the water-bindered pill is made.
Preparation method two: taking above-mentioned raw materials medicine by the parts by weight, takes Radix Notoginseng, rheum officinale, pearl processed, is put into ether, surpasses
Sonication 40Min, filtering, discards filtrate, takes filter residue, is sequentially placed into ethyl acetate, 65% ethyl alcohol, in 80% ethyl alcohol, and 40-
Under the conditions of 50 DEG C, it is ultrasonically treated 1h respectively, filters, what combined ethyl acetate extraction, 65% ethyl alcohol extraction, 80% ethyl alcohol extracted
Filtrate is concentrated in filtrate, makes liquid content 10% -20%, then mix with other bulk pharmaceutical chemicals (Cortex Eucommiae, safflower, borneol) powder, is made
The water-bindered pill.
Usage and dosage: with (in addition to auxiliary material) containing main medicine calculation, a 1.5-2.5g, 3 times a day.
Newly-increased bulk pharmaceutical chemicals analysis:
Radix Notoginseng, Panax Notoginseng also known as pseudo-ginseng, be Umbellales Araliaceae, containing vegetable fat, black pure and mild alkynes,
Alkene, hydrocarbon compound.Scientist has got cupreol from Roots of Panax Notoginseng, flower, fruit, has reducing blood lipid and anti-skin ulcer
The effects of.From the isolated ene-alkyne hydrocarbon compound-panaxytiol (panaxytriol) of the fatty contents of Roots of Panax Notoginseng,
The compound is the aminoacid ingredient in Radix Notoginseng.Its root has the effect of dissipating stasis and stanching bleeding, detumescence ding-tong as medicinal effects.
Hemoptysis is cured mainly, haematemesis, bleeding from five sense organs or subcutaneous tissue, hematochezia, metrorrhagia and metrostaxis, traumatic hemorrhage, chest and abdomen shouting pain falls servant's swelling and pain, and has stronger anti-cancer and resist
Cancer effect.Currently, being separated to 17 kinds of amino acid in mountain of papers Radix Notoginseng, having 7 kinds is that body body is required, wherein there is a kind of special acid to claim
For dencichine (dencichine), there is extraordinary anastalsis.Several rare Chinese medicines of Panax contain hemostatic compositions
Dencichine, but with Radix Notoginseng content highest (0.90%), ginseng takes second place (0.50%), and American Ginseng is minimum (0.31%), therefore, Radix Notoginseng
Styptic activity is best.
Rheum officinale, RheumpalmatumL, nickname general are the perennial plants of a variety of polygonaceae Rheums, contain Chrysophanol
(Chrysophanol), rheum emodin (Emodin), Physcion (Physcion), aloe-emodin (Aloe-emodin), big
Yellow acid (Rhein), rheotannic acid (Rheum tannic acids) and its related substances, as gallic acid (Gallic acid),
Cachou extract (Cate- chin), tetrarin (Tetrarin), fatty acid, calcium oxalate, glucose, fruit sugar and starch etc..Enter
Pharmacological property taste: it is bitter, it trembles with fear.Return stomach meridian, large intestine channel, Liver Channel, the spleen channel, can removing damp-heat, for the jaundice of stagnation of damp-heat, difficult urination,
Dry and hard excrement;Also can cooling blood and hemostasis, be used for injury of blood collaterals by heat haematemesis, bleeding from five sense organs or subcutaneous tissue, hematochezia, metrorrhagia and metrostaxis, leukorrhea with reddish discharge.Modern clinic is available
It is yellow in treatment epidemic meningitis, lobar pneumonia, acute biliary infection, acute parotidits, acute appendicitis, acute infective
Subcutaneous ulcer type hepatitis, chordapsus, bacillary dysentery, hemorrhage of digestive tract, sphagitis, parulis, dermatitis, eczema, stranguria syndrome, band-like blister
Rash etc..It fries charcoal and is usually used in cooling blood and hemostasis.
Pearl processed, dairy pearl.Anaesthetic name sweeps Bu De " errorless anaesthetic mirror ", different name male ground lattice.It is dynamic from Pteriidae
Shape in the shell-fishes pearl sac such as object pearl shell, Pinctada martensii or Unionidae animal hydriopsis cumingii, anodonta woodiana pacifica, cristaria plicata
At without nucleus pearl.The pearl of pearl shell mainly contains calcium carbonate 92%, organic matter about 5%, metallic element have aluminium, copper, iron, magnesium,
Manganese, sodium, zinc, silicon, titanium etc..Still containing amino acid such as histidine, arginine, threonine, serines.The pearl of Pinctada martensii contains
There are 16 kinds of inorganic elements, based on calcium carbonate, secondary is the compound of silicon, sodium, magnesium, and keratin contains 16 kinds of amino acid, with the third ammonia
The content of acid and glycine is higher, and secondary is aspartic acid, leucine and arginine, still contains taurine.The pearl of triangle freshwater mussel, which breathes out, to be had
20 kinds of inorganic elements, highest content is calcium, is secondly sodium, is additionally rich in amino acid, wherein glycine and alanine content
Higher, threonine content is very low.20 kinds of inorganic elements such as the pearl calcic of cristaria plicata, sodium, magnesium, strontium, iron, manganese and carbonate,
Oxalic acid is with equal acid radical anions, containing 15 kinds or more of amino acid, wherein secondary is asparagus fern with the content highest of glycine, alanine
Propylhomoserin, serine, leucine.The effects of pharmacological action: delaying senescence, anti-oxidant, antitumor.Process: dairy pearl takes treasure
Pearl, size is separated, and big person is pounded into fritter, merged with small person, sets and boils 4-6h in milk or ewe's milk, takes out, dry.Pharmacological property: taste
It is bitter, salty, it is mild-natured.Major function: removing toxic substances, calmness, feeding brain, more arteries and veins.Cure mainly toxication, encephalomyelopathy, apoplexy, white vein, gout, trip pain
Disease, sore.
Prescription analysis: experiment is selected by a large amount of bulk pharmaceutical chemicals, the cupreol is substituted by Radix Notoginseng, the rheum officinale
Element is substituted by rheum officinale, the calcium carbonate, glycine, and alanine is substituted by pearl processed, and will in the preparation method of optimization
Radix Notoginseng, rheum officinale, pearl processed are extracted, under the premise of finding with the accurate compatibility of Cortex Eucommiae, in the base for guaranteeing drug effect
On plinth, drug cost is further decreased.
Preparation method analysis: Radix Notoginseng, rheum officinale, pearl processed are first removed into partial invalidity ingredient with ether, using acetic acid respectively
Ethyl ester, 65% ethyl alcohol, 80% ethyl alcohol extract active component, this processing method, relatively only with Radix Notoginseng, rheum officinale, pearl raw material processed
Medicine further increases the accuracy with Cortex Eucommiae compatibility, then water-bindered pill agent processed is mixed with other drugs, and the purpose is to guarantee drug effect
On the basis of, further decrease drug cost.Also ingredient confirms that this is theoretical to experimental result, under equal conditions, using second
The therapeutic effect that kind preparation method obtains is higher than the first preparation method, and cure rate, effective percentage, which have, averagely improves 2-4
Percentage point.Preferably second of preparation method, experiment content and data are as follows below.
With reference to " clinical disease diagnosis is according to the criteria for recovery " (second edition), the medical officer people is published, and edits Sun Chuanxing, knot
Feature of the present invention is closed, healing improvement standard of the invention is formulated.
Cure: union, bone function are wholly or substantially restored.
It improves: aligning and be fixed well, wound healing after operation, feeling of pain mitigates.
Invalid: symptom is not any change, and X-ray examination is not any change.
Since 2002, using set a broken bone patient 128 of the present invention, wherein 32 people of Patients with Bone Fracture, fracture of tibia
32 people of patient, 32 people of patellar fracture patient, 32 people of ankle fracture patient, experiment case pass through the attached doctor of National University of the Inner Mongol
Institute's diagnosis is made a definite diagnosis, and disease type, number of cases and treatment condition are as follows:
Calculation formula: cure rate=(curing number/sum) × 100%, total effective rate=(sum-invalid number)/sum ×
100%。
As it can be seen that being existed using the cure rate of present invention treatment femoral fracture, fracture of tibia, patellar fracture, ankle fracture
62.5% or more, for total effective rate 84.3% or more, average cure rate is 63.3%, and average total effective rate is 87.5%.Averagely control
More rate reduces by 5.9 percentage points compared with second of embodiment, and average total effective rate reduces by 3.3 percentage points compared with second of embodiment.
Therapeutic effect has no significant change, and therefore, above-mentioned raw materials medicine can be used as substitute, to reduce the cost of drug, expands medicine
The scope of application of object has wide prospect of the application especially to basic hospital.
In addition, follow-up investigation, drug does not generate any toxic side effect to patient.
4th kind of embodiment: on the basis of second of embodiment, described 0.5-0.8 part of cupreol by 10-12 parts
Wood of shiny-leaved yellowhorn substitution, described 0.2-0.3 part of rheum emodin is substituted by 4-6 parts of rheum officinales, 0.5-1 parts of the calcium carbonate, glycine
0.1-0.2 part, 0.1-0.2 part of alanine is substituted by 4-6 parts of pearls processed.That is: Cortex Eucommiae 18-22 parts, 10-12 parts of wood of shiny-leaved yellowhorn, greatly
It is 4-6 parts yellow, pearl 4-6 parts processed, 12-18 parts of safflower, 0.5-1.5 parts of borneol.It is preferred that: 20 parts of Cortex Eucommiae, 11 parts of wood of shiny-leaved yellowhorn, rheum officinale 5
Part, 5 parts of pearl processed, 15 parts of safflower, 1 part of borneol.
Preparation method one: above-mentioned raw materials medicine is taken by weight, it may be assumed that Cortex Eucommiae, wood of shiny-leaved yellowhorn, rheum officinale, pearl processed, safflower, borneol,
It crushes, sieves with 100 mesh sieve, add water, the water-bindered pill is made.
Preparation method two: taking above-mentioned raw materials medicine by the parts by weight, takes wood of shiny-leaved yellowhorn, rheum officinale, pearl processed, is put into ether,
It is ultrasonically treated 40Min, filtering discards filtrate, takes filter residue, it is sequentially placed into ethyl acetate, 65% ethyl alcohol, in 80% ethyl alcohol,
Under the conditions of 40-50 DEG C, it is ultrasonically treated 1h respectively, filters, combined ethyl acetate extraction, 65% ethyl alcohol extraction, 80% ethyl alcohol mention
Filtrate is concentrated in the filtrate taken, makes liquid content 10% -20%, then mix with other bulk pharmaceutical chemicals (Cortex Eucommiae, safflower, borneol) powder,
The water-bindered pill is made.
Usage and dosage: with (in addition to auxiliary material) containing main medicine calculation, a 1.5-2.5g, 3 times a day.
Newly-increased bulk pharmaceutical chemicals analysis:
Wood of shiny-leaved yellowhorn, Mongolian name monk steps on, the rich heat of He E mattress Tao Laiyin-, Ge Reletuji wood this, Xi La-monk steps on.For no trouble
The dry duramen of scarabaeidae plant shiny-leaved yellowhorn (Xanthoccerassorbifolia Bunge).This product is sweet in flavor, puckery, slight bitter, cool in nature,
It is dry, puckery, floating, light.There is the effect of dry yellow water, heat-clearing, detumescence, analgesic.For joint pain, dyskinesia, the Huangs such as pruitus
Water spreads disease and heart grasserie etc..In wood of shiny-leaved yellowhorn containing rheum emodin, Physcion, cupreol, stigmasterol, Chrysophanol,
The ingredients such as Quercetin.
Prescription analysis: experiment is selected by a large amount of bulk pharmaceutical chemicals, the cupreol is substituted by wood of shiny-leaved yellowhorn, and described is big
Flavine is substituted by rheum officinale, the calcium carbonate, glycine, and alanine is substituted by pearl processed, and in the preparation method of optimization
Wood of shiny-leaved yellowhorn, rheum officinale, pearl processed are extracted, under the premise of finding with the accurate compatibility of Cortex Eucommiae, guaranteeing drug effect
On the basis of, further decrease drug cost.
Preparation method analysis: wood of shiny-leaved yellowhorn, rheum officinale, pearl processed are first removed into partial invalidity ingredient with ether, using second respectively
Acetoacetic ester, 65% ethyl alcohol, 80% ethyl alcohol extract active component, this processing method, relatively only with wood of shiny-leaved yellowhorn, rheum officinale, pearl processed
Bulk pharmaceutical chemicals further increase the accuracy with Cortex Eucommiae compatibility, then water-bindered pill agent processed is mixed with other drugs, and the purpose is to guarantee
On the basis of drug effect, drug cost is further decreased.Also ingredient confirms that this is theoretical to experimental result, under equal conditions, uses
The therapeutic effect that second of preparation method obtains is higher than the first preparation method, and cure rate, effective percentage, which have, averagely to be improved
3-4 percentage points.Preferably second of preparation method, experiment content and data are as follows below.
With reference to " clinical disease diagnosis is according to the criteria for recovery " (second edition), the medical officer people is published, and edits Sun Chuanxing, knot
Feature of the present invention is closed, healing improvement standard of the invention is formulated.
Cure: union, bone function are wholly or substantially restored.
It improves: aligning and be fixed well, wound healing after operation, feeling of pain mitigates.
Invalid: symptom is not any change, and X-ray examination is not any change.
Since 2006, using set a broken bone patient 130 of the present invention, wherein 33 people of Patients with Bone Fracture, fracture of tibia
32 people of patient, 32 people of patellar fracture patient, 33 people of ankle fracture patient, experiment case pass through the attached doctor of National University of the Inner Mongol
Institute's diagnosis is made a definite diagnosis, and disease type, number of cases and treatment condition are as follows:
Calculation formula: cure rate=(curing number/sum) × 100%, total effective rate=(sum-invalid number)/sum ×
100%。
As it can be seen that being existed using the cure rate of present invention treatment femoral fracture, fracture of tibia, patellar fracture, ankle fracture
62.5% or more, for total effective rate 84.3% or more, average cure rate is 63.8%, and average total effective rate is 86.9%.Averagely control
More rate reduces by 5.4 percentage points compared with second of embodiment, and average total effective rate reduces by 3.9 percentage points compared with second of embodiment.
Therapeutic effect has no significant change, and therefore, above-mentioned raw materials medicine can be used as substitute, to reduce the cost of drug, expands medicine
The scope of application of object has wide prospect of the application especially to basic hospital.
In addition, follow-up investigation, drug does not generate any toxic side effect to patient.
5th kind of embodiment: on the basis of second of embodiment, described 0.5-0.8 part of cupreol by 10-12 parts
The root of straight ladybell substitution, described 0.2-0.3 part of rheum emodin is substituted by 4-6 parts of rheum officinales, 0.5-1 parts of the calcium carbonate, glycine
0.1-0.2 part, 0.1-0.2 part of alanine is substituted by 4-6 parts of pearls processed.That is: Cortex Eucommiae 18-22 parts, 10-12 parts of the root of straight ladybell, rheum officinale
4-6 parts, pearl 4-6 parts processed, 12-18 parts of safflower, 0.5-1.5 parts of borneol.It is preferred that: 20 parts of Cortex Eucommiae, 11 parts of the root of straight ladybell, 5 parts of rheum officinale, system
5 parts of pearl, 15 parts of safflower, 1 part of borneol.
Preparation method one: above-mentioned raw materials medicine is taken by weight, it may be assumed that Cortex Eucommiae, the root of straight ladybell, rheum officinale, pearl processed, safflower, borneol, powder
It is broken, it sieves with 100 mesh sieve, adds water, the water-bindered pill is made.
Preparation method two: taking above-mentioned raw materials medicine by the parts by weight, takes the root of straight ladybell, rheum officinale, pearl processed, is put into ether, surpasses
Sonication 40Min, filtering, discards filtrate, takes filter residue, is sequentially placed into ethyl acetate, 65% ethyl alcohol, in 80% ethyl alcohol, and 40-
Under the conditions of 50 DEG C, it is ultrasonically treated 1h respectively, filters, what combined ethyl acetate extraction, 65% ethyl alcohol extraction, 80% ethyl alcohol extracted
Filtrate is concentrated in filtrate, makes liquid content 10% -20%, then mix with other bulk pharmaceutical chemicals (Cortex Eucommiae, safflower, borneol) powder, is made
The water-bindered pill.
Usage and dosage: with (in addition to auxiliary material) containing main medicine calculation, a 1.5-2.5g, 3 times a day.
Newly-increased bulk pharmaceutical chemicals analysis:
The root of straight ladybell, Adenophora stricta alias: adenophora tetraphylla, bubble ginseng, bubble the root of straight ladybell.According to relevant information, in the root of adenophora tetraphylla
Root containing triterpenoid saponin and starch glehnia littoralis contains alkaloid, starch abundant;Fruit (Phellopterin) containing phellopterin,
And analyse osthole (Imperatorin), bergapten (Bergapten), the root of various Lady bell medicinal plants are fat-soluble
Contain palmityl cupreol, lupenone, cupreol and 24- methylene-cycloartanol the root of straight ladybell taste in ingredient
It is sweet;Slight bitter;Cold nature;Return lung;Stomach meridian.Can clearing heat and nourishing yin, moistening lung to arrest cough has eliminating the phlegm, heart tonifying, antipyretic, analgesia, antimycotic etc.
Effect is usually used in treating tracheitis, pertussis, cough with lung heat, cough up phlegm yellow thick.
Prescription analysis: experiment is selected by a large amount of bulk pharmaceutical chemicals, the cupreol is substituted by the root of straight ladybell, the rheum officinale
Element is substituted by rheum officinale, the calcium carbonate, glycine, and alanine is substituted by pearl processed, and will in the preparation method of optimization
The root of straight ladybell, rheum officinale, pearl processed are extracted, under the premise of finding with the accurate compatibility of Cortex Eucommiae, in the base for guaranteeing drug effect
On plinth, drug cost is further decreased.
Preparation method analysis: the root of straight ladybell, rheum officinale, pearl processed are first removed into partial invalidity ingredient with ether, using acetic acid respectively
Ethyl ester, 65% ethyl alcohol, 80% ethyl alcohol extract active component, this processing method, relatively only with the root of straight ladybell, rheum officinale, pearl raw material processed
Medicine further increases the accuracy with Cortex Eucommiae compatibility, then water-bindered pill agent processed is mixed with other drugs, and the purpose is to guarantee drug effect
On the basis of, further decrease drug cost.Also ingredient confirms that this is theoretical to experimental result, under equal conditions, using second
The therapeutic effect that kind preparation method obtains is higher than the first preparation method, and cure rate, effective percentage, which have, averagely improves 2-4
Percentage point.Preferably second of preparation method, experiment content and data are as follows below.
With reference to " clinical disease diagnosis is according to the criteria for recovery " (second edition), the medical officer people is published, and edits Sun Chuanxing, knot
Feature of the present invention is closed, healing improvement standard of the invention is formulated.
Cure: union, bone function are wholly or substantially restored.
It improves: aligning and be fixed well, wound healing after operation, feeling of pain mitigates.
Invalid: symptom is not any change, and X-ray examination is not any change.
Since 2007, using set a broken bone patient 131 of the present invention, wherein 32 people of Patients with Bone Fracture, fracture of tibia
34 people of patient, 32 people of patellar fracture patient, 33 people of ankle fracture patient, experiment case pass through the attached doctor of National University of the Inner Mongol
Institute's diagnosis is made a definite diagnosis, and disease type, number of cases and treatment condition are as follows:
Calculation formula: cure rate=(curing number/sum) × 100%, total effective rate=(sum-invalid number)/sum ×
100%。
As it can be seen that being existed using the cure rate of present invention treatment femoral fracture, fracture of tibia, patellar fracture, ankle fracture
59.3% or more, for total effective rate 84.3% or more, average cure rate is 62.3%, and average total effective rate is 88.5%.Averagely control
More rate reduces by 6.9 percentage points compared with second of embodiment, and average total effective rate reduces by 2.3 percentage points compared with second of embodiment.
Therapeutic effect has no too big variation, and therefore, above-mentioned raw materials medicine can be used as substitute, to reduce the cost of drug, expands medicine
The scope of application of object has wide prospect of the application especially to basic hospital.
In addition, follow-up investigation, drug does not generate any toxic side effect to patient.
6th kind of embodiment: on the basis of second of embodiment, described 0.5-0.8 part of cupreol by 12-18 parts
Radix Notoginseng substitution, described 0.2-0.3 part of rheum emodin is substituted by 4-6 parts of rheum officinales, 0.5-1 parts of the calcium carbonate, glycine
0.1-0.2 part, 0.1-0.2 part of alanine is substituted by 2-4 parts of keel.That is: Cortex Eucommiae 18-22 parts, 12-18 parts of Radix Notoginseng, rheum officinale 4-6
Part, 2-4 parts of keel, 12-18 parts of safflower, 0.5-1.5 parts of borneol.It is preferred that: 20 parts of Cortex Eucommiae, 15 parts of Radix Notoginseng, 5 parts of rheum officinale, keel 3
Part, 15 parts of safflower, 1 part of borneol.
Preparation method one: above-mentioned raw materials medicine is taken by weight, it may be assumed that Cortex Eucommiae, Radix Notoginseng, rheum officinale, keel, safflower, borneol, powder
It is broken, it sieves with 100 mesh sieve, adds water, the water-bindered pill is made.
Production method two: taking above-mentioned raw materials medicine by the parts by weight, take Radix Notoginseng, rheum officinale, keel, be put into ether, ultrasound
40Min is handled, filtering discards filtrate, takes filter residue, it is sequentially placed into ethyl acetate, 65% ethyl alcohol, in 80% ethyl alcohol, 40-50
Under the conditions of DEG C, it is ultrasonically treated 1h respectively, filters, the filter that combined ethyl acetate extraction, 65% ethyl alcohol extraction, 80% ethyl alcohol extract
Filtrate is concentrated in liquid, makes liquid content 10% -20%, then mix with other bulk pharmaceutical chemicals (Cortex Eucommiae, safflower, borneol) powder, water is made
Ball.
Usage and dosage: with (in addition to auxiliary material) containing main medicine calculation, a 1.5-2.5g, 3 times a day.
Newly-increased bulk pharmaceutical chemicals analysis:
Keel, Mongolian name Lu-Ya Si, different name cloth such as lattice are auspicious, alias: Lu Hu loses life, that gal bone, Os Draconis, calcined Dragon's bone, five Hua Long
Bone, bluenessization keel, OS DRACONIS, white keel.For ancient times mammal as if the fossil of the skeleton of class, rhinoceros class, Hippocampal cortex etc..Change
It studies point: main hydroxyl calcium phosphate Ca5(PO4) 3(OH) (hydroxyapatite);Still contain a small amount of calcium carbonate and iron, aluminium, magnesium, manganese, strontium etc.
Element.Pharmacological property: sweet in flavor, puckery, mild-natured, major function: killing viscous, only shouting pain, only rotten, myogenic holds back wound and calms the nerves.
Prescription analysis: experiment is selected by a large amount of bulk pharmaceutical chemicals, the cupreol is substituted by Radix Notoginseng, the rheum officinale
Element is substituted by rheum officinale, the calcium carbonate, glycine, and alanine is substituted by keel.And by three in the preparation method of optimization
Seven, rheum officinale, keel are extracted, under the premise of finding with the accurate compatibility of Cortex Eucommiae, on the basis of guaranteeing drug effect,
Further decrease drug cost.
Preparation method analysis: Radix Notoginseng, rheum officinale, keel are first removed into partial invalidity ingredient with ether, are using acetic acid second respectively
Ester, 65% ethyl alcohol, 80% ethyl alcohol extract active component, this processing method, more only with Radix Notoginseng, rheum officinale, keel bulk pharmaceutical chemicals into
One step increases the accuracy with Cortex Eucommiae compatibility, then water-bindered pill agent processed is mixed with other drugs, and the purpose is in the base for guaranteeing drug effect
On plinth, drug cost is further decreased.Also ingredient confirms that this is theoretical to experimental result, under equal conditions, is made using second
The therapeutic effect that Preparation Method obtains is higher than the first preparation method, and cure rate, effective percentage, which have, averagely improves 2-4 percentage
Point.Preferably second of preparation method, experiment content and data are as follows below.
With reference to " clinical disease diagnosis is according to the criteria for recovery " (second edition), the medical officer people is published, and edits Sun Chuanxing, knot
Feature of the present invention is closed, healing improvement standard of the invention is formulated.
Cure: union, bone function are wholly or substantially restored.
It improves: aligning and be fixed well, wound healing after operation, feeling of pain mitigates.
Invalid: symptom is not any change, and X-ray examination is not any change.
Since 2008, using set a broken bone patient 133 of the present invention, wherein 33 people of Patients with Bone Fracture, fracture of tibia
33 people of patient, 34 people of patellar fracture patient, 33 people of ankle fracture patient, experiment case pass through the attached doctor of National University of the Inner Mongol
Institute's diagnosis is made a definite diagnosis, and disease type, number of cases and treatment condition are as follows:
Calculation formula: cure rate=(curing number/sum) × 100%, total effective rate=(sum-invalid number)/sum ×
100%。
As it can be seen that being existed using the cure rate of present invention treatment femoral fracture, fracture of tibia, patellar fracture, ankle fracture
61.8% or more, for total effective rate 85.3% or more, average cure rate is 64.7%, and average total effective rate is 88.0%.Averagely control
More rate reduces by 4.5 percentage points compared with second of embodiment, and average total effective rate reduces by 2.8 percentage points compared with second of embodiment.
Therapeutic effect has no too big variation, and therefore, above-mentioned raw materials medicine can be used as substitute, to reduce the cost of drug, expands medicine
The scope of application of object has wide prospect of the application especially to basic hospital.
In addition, follow-up investigation, drug does not generate any toxic side effect to patient.
7th kind of embodiment: on the basis of second of embodiment, described 0.5-0.8 part of cupreol by 10-12 parts
Wood of shiny-leaved yellowhorn substitution, described 0.2-0.3 part of rheum emodin is substituted by 4-6 parts of rheum officinales, 0.5-1 parts of the calcium carbonate, glycine
0.1-0.2 part, 0.1-0.2 part of alanine is substituted by 2-4 parts of keel.That is: Cortex Eucommiae 18-22 parts, 10-12 parts of wood of shiny-leaved yellowhorn, rheum officinale
4-6 parts, 2-4 parts of keel, 12-18 parts of safflower, 0.5-1.5 parts of borneol.It is preferred that: 20 parts of Cortex Eucommiae, 11 parts of wood of shiny-leaved yellowhorn, 5 parts of rheum officinale, dragon
3 parts of bone, 15 parts of safflower, 1 part of borneol.
Preparation method one: above-mentioned raw materials medicine is taken by weight, it may be assumed that Cortex Eucommiae, wood of shiny-leaved yellowhorn, rheum officinale, keel, safflower, borneol, powder
It is broken, it sieves with 100 mesh sieve, adds water, the water-bindered pill is made.
Preparation method two: taking above-mentioned raw materials medicine by the parts by weight, and wood of shiny-leaved yellowhorn, rheum officinale, keel are put into ether, ultrasound
40Min is handled, filtering discards filtrate, takes filter residue, it is sequentially placed into ethyl acetate, 65% ethyl alcohol, in 80% ethyl alcohol, 40-50
Under the conditions of DEG C, it is ultrasonically treated 1h respectively, filters, the filter that combined ethyl acetate extraction, 65% ethyl alcohol extraction, 80% ethyl alcohol extract
Filtrate is concentrated in liquid, makes liquid content 10% -20%, then mix with other bulk pharmaceutical chemicals (Cortex Eucommiae, safflower, borneol) powder, water is made
Ball.
Usage and dosage: with (in addition to auxiliary material) containing main medicine calculation, a 1.5-2.5g, 3 times a day.
Prescription analysis: experiment is selected by a large amount of bulk pharmaceutical chemicals, the cupreol is substituted by wood of shiny-leaved yellowhorn, and described is big
Flavine is substituted by rheum officinale, the calcium carbonate, glycine, and alanine is substituted by keel.And it will in the preparation method of optimization
Wood of shiny-leaved yellowhorn, rheum officinale, keel are extracted, under the premise of finding with the accurate compatibility of Cortex Eucommiae, in the base for guaranteeing drug effect
On plinth, drug cost is further decreased.
Preparation method analysis: wood of shiny-leaved yellowhorn, rheum officinale, keel are first removed into partial invalidity ingredient with ether, are using acetic acid respectively
Ethyl ester, 65% ethyl alcohol, 80% ethyl alcohol extract active component, and this processing method more only uses wood of shiny-leaved yellowhorn, rheum officinale, keel raw material
Medicine further increases the accuracy with Cortex Eucommiae compatibility, then water-bindered pill agent processed is mixed with other drugs, and the purpose is to guarantee drug effect
On the basis of, further decrease drug cost.Also ingredient confirms that this is theoretical to experimental result, under equal conditions, using second
The therapeutic effect that kind preparation method obtains is higher than the first preparation method, and cure rate, effective percentage, which have, averagely improves 2-3
Percentage point.Preferably second of preparation method, experiment content and data are as follows below.
With reference to " clinical disease diagnosis is according to the criteria for recovery " (second edition), the medical officer people is published, and edits Sun Chuanxing, knot
Feature of the present invention is closed, healing improvement standard of the invention is formulated.
Cure: union, bone function are wholly or substantially restored.
It improves: aligning and be fixed well, wound healing after operation, feeling of pain mitigates.
Invalid: symptom is not any change, and X-ray examination is not any change.
Since 2010, using set a broken bone patient 130 of the present invention, wherein 33 people of Patients with Bone Fracture, fracture of tibia
32 people of patient, 32 people of patellar fracture patient, 33 people of ankle fracture patient, experiment case pass through the attached doctor of National University of the Inner Mongol
Institute's diagnosis is made a definite diagnosis, and disease type, number of cases and treatment condition are as follows:
Calculation formula: cure rate=(curing number/sum) × 100%, total effective rate=(sum-invalid number)/sum ×
100%。
As it can be seen that being existed using the cure rate of present invention treatment femoral fracture, fracture of tibia, patellar fracture, ankle fracture
57.6% or more, for total effective rate 84.8% or more, average cure rate is 63.1%, and average total effective rate is 87.7%.Averagely control
More rate reduces by 6.1 percentage points compared with second of embodiment, and average total effective rate reduces by 3.1 percentage points compared with second of embodiment.
Therapeutic effect has no significant change, and therefore, above-mentioned raw materials medicine can be used as substitute, to reduce the cost of drug, expands medicine
The scope of application of object has wide prospect of the application especially to basic hospital.
In addition, follow-up investigation, drug does not generate any toxic side effect to patient.
8th kind of embodiment: on the basis of second of embodiment, described 0.5-0.8 part of cupreol by 10-12 parts
The root of straight ladybell substitution, described 0.2-0.3 part of rheum emodin is substituted by 4-6 rheum officinales, 0.5-1 parts of the calcium carbonate, glycine 0.1-
0.2 part, 0.1-0.2 part of alanine is substituted by 2-4 parts of keel.That is: Cortex Eucommiae 18-22 parts, 10-12 parts of the root of straight ladybell, 4-6 parts of rheum officinale, dragon
2-4 parts of bone, 12-18 parts of safflower, 0.5-1.5 parts of borneol.It is preferred that: 20 parts of Cortex Eucommiae, 11 parts of the root of straight ladybell, 5 parts of rheum officinale, 3 parts of keel, safflower
15 parts, 1 part of borneol.
Preparation method one: above-mentioned raw materials medicine is taken by weight, it may be assumed that Cortex Eucommiae, the root of straight ladybell, rheum officinale, keel, safflower, borneol, powder
It is broken, it sieves with 100 mesh sieve, adds water, the water-bindered pill is made.
Preparation method two: taking above-mentioned raw materials medicine by the parts by weight, take the root of straight ladybell, rheum officinale, keel, be put into ether, ultrasound
40Min is handled, filtering discards filtrate, takes filter residue, it is sequentially placed into ethyl acetate, 65% ethyl alcohol, in 80% ethyl alcohol, 40-50
Under the conditions of DEG C, it is ultrasonically treated 1h respectively, filters, the filter that combined ethyl acetate extraction, 65% ethyl alcohol extraction, 80% ethyl alcohol extract
Filtrate is concentrated in liquid, makes liquid content 10% -20%, then mix with other bulk pharmaceutical chemicals (Cortex Eucommiae, safflower, borneol) powder, water is made
Ball.
Usage and dosage: with (in addition to auxiliary material) containing main medicine calculation, a 1.5-2.5g, 3 times a day.
Prescription analysis: experiment is selected by a large amount of bulk pharmaceutical chemicals, the cupreol is substituted by the root of straight ladybell, the rheum officinale
Element is substituted by rheum officinale, the calcium carbonate, glycine, and alanine is substituted by keel.And it will be husky in the preparation method of optimization
Ginseng, rheum officinale, keel are extracted, under the premise of finding with the accurate compatibility of Cortex Eucommiae, on the basis of guaranteeing drug effect,
Further decrease drug cost.
Preparation method analysis: the root of straight ladybell, rheum officinale, keel are first removed into partial invalidity ingredient with ether, are using acetic acid second respectively
Ester, 65% ethyl alcohol, 80% ethyl alcohol extract active component, this processing method, more only with the root of straight ladybell, rheum officinale, keel bulk pharmaceutical chemicals into
One step increases the accuracy with Cortex Eucommiae compatibility, then water-bindered pill agent processed is mixed with other drugs, and the purpose is in the base for guaranteeing drug effect
On plinth, drug cost is further decreased.Also ingredient confirms that this is theoretical to experimental result, under equal conditions, is made using second
The therapeutic effect that Preparation Method obtains is higher than the first preparation method, and cure rate, effective percentage, which have, averagely improves 2-4 percentage
Point.Preferably second of preparation method, experiment content and data are as follows below.
With reference to " clinical disease diagnosis is according to the criteria for recovery " (second edition), the medical officer people is published, and edits Sun Chuanxing, knot
Feature of the present invention is closed, healing improvement standard of the invention is formulated.
Cure: union, bone function are wholly or substantially restored.
It improves: aligning and be fixed well, wound healing after operation, feeling of pain mitigates.
Invalid: symptom is not any change, and X-ray examination is not any change.
Since 2011, using set a broken bone patient 131 of the present invention, wherein 33 people of Patients with Bone Fracture, fracture of tibia
33 people of patient, 32 people of patellar fracture patient, 33 people of ankle fracture patient, experiment case pass through the attached doctor of National University of the Inner Mongol
Institute's diagnosis is made a definite diagnosis, and disease type, number of cases and treatment condition are as follows: experiment case and pass through Affiliated Hospital of Inner Mongolia University for the Nationalities
Diagnosis is made a definite diagnosis, and disease type, number of cases and treatment condition are as follows:
Calculation formula: cure rate=(curing number/sum) × 100%, total effective rate=(sum-invalid number)/sum ×
100%。
As it can be seen that being existed using the cure rate of present invention treatment femoral fracture, fracture of tibia, patellar fracture, ankle fracture
60.6% or more, for total effective rate 84.8% or more, average cure rate is 64.1%, and average total effective rate is 90.1%.Averagely control
More rate reduces by 5.1 percentage points compared with second of embodiment, and average total effective rate reduces by 0.7 percentage point compared with second of embodiment.
Therapeutic effect has no significant change, and therefore, above-mentioned raw materials medicine can be used as substitute, to reduce the cost of drug, expands medicine
The scope of application of object has wide prospect of the application especially to basic hospital.
In addition, follow-up investigation, drug does not generate any toxic side effect to patient.
9th kind of embodiment: on the basis of the 8th kind of embodiment, the raw material medicaments in part by weight adds 3-5 parts of climbing groundsel,
4-6 parts of blood of goats.That is: Cortex Eucommiae 18-22 parts, 10-12 parts of the root of straight ladybell, 4-6 parts of rheum officinale, 2-4 parts of keel, 12-18 parts of safflower, borneol
0.5-1.5 parts, 3-5 parts of climbing groundsel, 4-6 parts of blood of goats.It is preferred that: it is 20 parts of Cortex Eucommiae, 11 parts of the root of straight ladybell, 5 parts of rheum officinale, 3 parts of keel, red
Spend 15 parts, 1 part of borneol, 4 parts of climbing groundsel, 5 parts of blood of goats.
Preparation method one: above-mentioned raw materials medicine is taken by weight, it may be assumed that Cortex Eucommiae, the root of straight ladybell, rheum officinale, keel, safflower, borneol, a thousand li
Light, blood of goats crush, sieve with 100 mesh sieve, add water, the water-bindered pill is made.
Preparation method two: taking above-mentioned raw materials medicine by the parts by weight, take the root of straight ladybell, rheum officinale, keel, be put into ether, ultrasound
40Min is handled, filtering discards filtrate, takes filter residue, it is sequentially placed into ethyl acetate, 65% ethyl alcohol, in 80% ethyl alcohol, 40-50
Under the conditions of DEG C, it is ultrasonically treated 1h respectively, filters, the filter that combined ethyl acetate extraction, 65% ethyl alcohol extraction, 80% ethyl alcohol extract
Liquid is concentrated filtrate, makes liquid content 10% -20%, then with other bulk pharmaceutical chemicals (Cortex Eucommiae, safflower, borneol, climbing groundsel, blood of goats) powder
End mixes, and the water-bindered pill is made.
Usage and dosage: with (in addition to auxiliary material) containing main medicine calculation, a 1.5-3.0g, 3 times a day.
Newly-increased bulk pharmaceutical chemicals analysis:
Climbing groundsel, Mongolian name Ge Qi is to slow, and different name Gu is auspicious, ancient auspicious mamba " errorless anaesthetic mirror ", the clear conspicuous door of Wu Douli lattice-, Wu Dou
Power lattice-are black odd to slow " anaesthetic ".For the wounded in the battle aerial part of compositae plant Senecio argunensis.Pharmacological property: bitter, it is cold in nature.Effect
Gently, rough, blunt.Major function: restrain, connect arteries and veins, only shouting pain, heat-clearing, removing toxic substances.Bone fracture is cured mainly, arteries and veins wound glues epidemic disease, bloody flux, internal organs heat.
Blood of goats, her numb red element of sound-of anaesthetic name, different name La Ha " errorless anaesthetic mirror ", from bovid goat
Blood.Pharmacological property: it is sweet in flavor, it is cool in nature.Major function: removing toxic substances, callus, synthetism, hemostasis, dry Xieri Wusu Symptom.Cure mainly syphilis, muscle damage
Wound, bone fracture, wound swelling and pain etc..
Prescription analysis: on the basis of the bulk pharmaceutical chemicals of the 8th kind of embodiment, the raw material medicaments in part by weight addition climbing groundsel,
Blood of goats, the convergence of a thousand li luminous energy connect arteries and veins, and only shouting pain assists Cortex Eucommiae swelling and pain relieving, and animal drugs blood of goats is added, and animal and plant medicine has
The effect of machine combines, and promotes the healing of bone fracture, the further bone-setting pain stopping for enhancing each medicine of prescription, said medicine Xiang Fuxiang
At, play altogether synthetism, swelling and pain relieving effect, thus treatment to various fracture caused by wound, each disease such as dislocation, soft tissue injury.
Preparation method analysis: the root of straight ladybell, rheum officinale, keel are first removed into partial invalidity ingredient with ether, are using acetic acid second respectively
Ester, 65% ethyl alcohol, 80% ethyl alcohol extract active component, this processing method, more only with the root of straight ladybell, rheum officinale, keel bulk pharmaceutical chemicals into
One step increases the accuracy with Cortex Eucommiae compatibility, then water-bindered pill agent processed is mixed with other drugs, and the purpose is in the base for guaranteeing drug effect
On plinth, drug cost is further decreased.Also ingredient confirms that this is theoretical to experimental result, under equal conditions, is made using second
The therapeutic effect that Preparation Method obtains is higher than the first preparation method, and cure rate, effective percentage, which have, averagely improves 3-5 percentage
Point.Preferably second of preparation method, experiment content and data are as follows below.
With reference to " clinical disease diagnosis is according to the criteria for recovery " (second edition), the medical officer people is published, and edits Sun Chuanxing, knot
Feature of the present invention is closed, healing improvement standard of the invention is formulated.
Cure: union, bone function are wholly or substantially restored.
It improves: aligning and be fixed well, wound healing after operation, feeling of pain mitigates.
Invalid: symptom is not any change, and X-ray examination is not any change.
Since 2012, using set a broken bone patient 160 of the present invention, wherein 40 people of Patients with Bone Fracture, fracture of tibia
39 people of patient, 41 people of patellar fracture patient, 40 people of ankle fracture patient, experiment case pass through the attached doctor of National University of the Inner Mongol
Institute's diagnosis is made a definite diagnosis, and disease type, number of cases and treatment condition are as follows: experiment case and pass through Affiliated Hospital of Inner Mongolia University for the Nationalities
Diagnosis is made a definite diagnosis, and disease type, number of cases and treatment condition are as follows:
Calculation formula: cure rate=(curing number/sum) × 100%, total effective rate=(sum-invalid number)/sum ×
100%。
As it can be seen that being existed using the cure rate of present invention treatment femoral fracture, fracture of tibia, patellar fracture, ankle fracture
65.8% or more, for total effective rate 87.5% or more, average cure rate is 63.8%, and average total effective rate is 86.9%.Averagely control
More rate improves 6.6 percentage points compared with the 8th kind of embodiment, and average total effective rate is unchanged compared with the 8th kind of embodiment, therefore, this
Embodiment has apparent progressive compared with the 8th kind of embodiment;Average cure rate improves 1.5 percentages compared with second of embodiment
Point, average total effective rate reduce 0.8 percentage point compared with second of embodiment.Therapeutic effect has almost no change, and has received meaning
Unimaginable effect.Therefore, above-mentioned raw materials medicine can be used as substitute, to reduce the cost of drug, expand being applicable in for drug
Range has wide prospect of the application.
In addition, follow-up investigation, drug does not generate any toxic side effect to patient.
Claims (11)
1. a kind of anaesthetic of bone-setting pain stopping, including Cortex Eucommiae, it is characterised in that: the Cortex Eucommiae and cupreol, rheum emodin, carbonic acid
Calcium, glycine, alanine compatibility, above-mentioned anaesthetic are prepared from the following raw materials in parts by weight: 18-22 parts of Cortex Eucommiae, cupreol
0.5-0.8 part, 0.2-0.3 part of rheum emodin, 0.5-1 parts of calcium carbonate, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine.
2. a kind of anaesthetic of bone-setting pain stopping according to claim 1, it is characterised in that: the raw material medicaments in part by weight is added
12-18 parts of safflower, 0.5-1.5 parts of borneol.
3. a kind of anaesthetic of bone-setting pain stopping according to claim 1 or 2, it is characterised in that: the cupreol 0.5-
0.8 part is substituted by 12-18 portions of Radix Notoginseng, and described 0.2-0.3 part of rheum emodin is substituted by 4-6 parts of rheum officinales, the calcium carbonate 0.5-
1 part, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine is substituted by 4-6 parts of pearls processed.
4. a kind of anaesthetic of bone-setting pain stopping according to claim 1 or 2, it is characterised in that: the cupreol 0.5-
0.8 part is substituted by 10-12 parts of wood of shiny-leaved yellowhorn, and described 0.2-0.3 part of rheum emodin is substituted by 4-6 parts of rheum officinales, the calcium carbonate
0.5-1 parts, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine is substituted by 4-6 parts of pearls processed.
5. a kind of anaesthetic of bone-setting pain stopping according to claim 1 or 2, it is characterised in that: the cupreol 0.5-
0.8 part is substituted by 10-12 parts of the root of straight ladybell, and described 0.2-0.3 part of rheum emodin is substituted by 4-6 parts of rheum officinales, the calcium carbonate 0.5-
1 part, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine is substituted by 4-6 parts of pearls processed.
6. a kind of anaesthetic of bone-setting pain stopping according to claim 1 or 2, it is characterised in that: the cupreol 0.5-
0.8 part is substituted by 12-18 portions of Radix Notoginseng, and described 0.2-0.3 part of rheum emodin is substituted by 4-6 parts of rheum officinales, the calcium carbonate 0.5-
1 part, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine is substituted by 2-4 parts of keel.
7. a kind of anaesthetic of bone-setting pain stopping according to claim 1 or 2, it is characterised in that: the cupreol 0.5-
0.8 part is substituted by 10-12 parts of wood of shiny-leaved yellowhorn, and described 0.2-0.3 part of rheum emodin is substituted by 4-6 parts of rheum officinales, the calcium carbonate
0.5-1 parts, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine is substituted by 2-4 parts of keel.
8. a kind of anaesthetic of bone-setting pain stopping according to claim 1 or 2, it is characterised in that: the cupreol 0.5-
0.8 part is substituted by 10-12 parts of the root of straight ladybell, and described 0.2-0.3 part of rheum emodin is substituted by 4-6 rheum officinale, the calcium carbonate 0.5-1
Part, 0.1-0.2 part of glycine, 0.1-0.2 part of alanine is substituted by 2-4 parts of keel.
9. a kind of anaesthetic of bone-setting pain stopping according to claim 8, it is characterised in that: the raw material medicaments in part by weight is added
3-5 parts of climbing groundsel, 4-6 parts of blood of goats.
10. a kind of a kind of preparation method of the anaesthetic of bone-setting pain stopping as described in any one of claim 1-9, feature
It is: takes above-mentioned raw materials medicine by weight, crush, sieve with 100 mesh sieve, mixes, add water, the water-bindered pill is made.
11. a kind of a kind of preparation of the anaesthetic of bone-setting pain stopping as described in claim 3 or 4 or 5 or 6 or 7 or 8 or 9
Method, it is characterised in that: take above-mentioned raw materials medicine by the parts by weight, take Radix Notoginseng, rheum officinale, pearl processed or wood of shiny-leaved yellowhorn, rheum officinale, system
Pearl or the root of straight ladybell, rheum officinale, pearl processed or Radix Notoginseng, rheum officinale, keel or wood of shiny-leaved yellowhorn, rheum officinale, keel or the root of straight ladybell, rheum officinale, keel,
Be put into ether, be ultrasonically treated 40Min, filtering, discard filtrate, take filter residue, be sequentially placed into ethyl acetate, 65% ethyl alcohol, 80%
Ethyl alcohol in, under the conditions of 40-50 DEG C, be ultrasonically treated 1h respectively, filter, combined ethyl acetate extracts, 65% ethyl alcohol extracts,
Filtrate is concentrated in the filtrate that 80% ethyl alcohol extracts, and makes liquid content 10% -20%, then mix with other bulk pharmaceutical chemicals powder, water is made
Ball.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811562621.3A CN109394824A (en) | 2018-12-20 | 2018-12-20 | A kind of anaesthetic of bone-setting pain stopping and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811562621.3A CN109394824A (en) | 2018-12-20 | 2018-12-20 | A kind of anaesthetic of bone-setting pain stopping and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109394824A true CN109394824A (en) | 2019-03-01 |
Family
ID=65460297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811562621.3A Pending CN109394824A (en) | 2018-12-20 | 2018-12-20 | A kind of anaesthetic of bone-setting pain stopping and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109394824A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111494578A (en) * | 2020-05-27 | 2020-08-07 | 苏雅拉图 | Mongolian medicine for promoting fracture healing and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101116674A (en) * | 2006-08-02 | 2008-02-06 | 奥·乌力吉 | Mongolian medicine for treating bone fracture |
CN101224268A (en) * | 2008-01-10 | 2008-07-23 | 强繁英 | Chinese traditional medicine for treating bone fracture, postoperative bone nonunion and delayed union and preparing method thereof |
CN101816357A (en) * | 2010-04-15 | 2010-09-01 | 肖永英 | Sedum aizoon L. tea |
CN102091234A (en) * | 2011-01-25 | 2011-06-15 | 王根保 | Traditional Chinese medicine composition for treating bone fracture diseases |
CN108743891A (en) * | 2018-06-13 | 2018-11-06 | 广东医品十方生物科技有限公司 | A kind of pure natural promoting blood circulation, removing blood stasis and relieving pain hydrogen-rich pharmaceutical composition and the preparation method and application thereof |
-
2018
- 2018-12-20 CN CN201811562621.3A patent/CN109394824A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101116674A (en) * | 2006-08-02 | 2008-02-06 | 奥·乌力吉 | Mongolian medicine for treating bone fracture |
CN101224268A (en) * | 2008-01-10 | 2008-07-23 | 强繁英 | Chinese traditional medicine for treating bone fracture, postoperative bone nonunion and delayed union and preparing method thereof |
CN101816357A (en) * | 2010-04-15 | 2010-09-01 | 肖永英 | Sedum aizoon L. tea |
CN102091234A (en) * | 2011-01-25 | 2011-06-15 | 王根保 | Traditional Chinese medicine composition for treating bone fracture diseases |
CN108743891A (en) * | 2018-06-13 | 2018-11-06 | 广东医品十方生物科技有限公司 | A kind of pure natural promoting blood circulation, removing blood stasis and relieving pain hydrogen-rich pharmaceutical composition and the preparation method and application thereof |
Non-Patent Citations (4)
Title |
---|
曾莉萍,等: "杜仲叶β-谷甾醇对成骨细胞和卵巢颗粒细胞的影响", 《时珍国医国药》 * |
李东,等: "杜仲的化学成分", 《JOURNAL OF INTEGRATIVE PLANT BIOLOGY》 * |
谭成钢,等: "浅谈大黄在骨伤科的应用", 《四川中医》 * |
赵文红,等: "补肾壮骨颗粒增强骨密度作用的动物实验研究", 《时珍国医国药》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111494578A (en) * | 2020-05-27 | 2020-08-07 | 苏雅拉图 | Mongolian medicine for promoting fracture healing and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100493553C (en) | Proprietary Chinese medicine for treating bone fracture | |
CN101732521B (en) | Medicinal composition for treating fracture and preparation method thereof | |
CN103877247B (en) | Medicine being used for the treatment of decubital ulcer and preparation method thereof | |
EA027651B1 (en) | Biologically active food additive for normalizing the function of the thyroid gland | |
CN110354236A (en) | A kind of pharmaceutical composition and preparation method thereof for treating sympotoms caused by cold factors | |
CN109394824A (en) | A kind of anaesthetic of bone-setting pain stopping and preparation method thereof | |
CN104435544A (en) | Traditional Chinese medicine oral liquid for treating leukemia through being cooperated with chemotherapy and preparation method thereof | |
CN106620402A (en) | Traditional Chinese medicine composition taken after operation of liver cancer and preparation method thereof | |
CN105031170A (en) | Healthcare foot bath powder and preparing method thereof | |
CN102824543A (en) | Yew anti-cancer paste | |
CN103961567A (en) | Medicine for treating gall-stone and muddy gall-stone | |
CN103893732B (en) | A kind of Tibetan medicine treating chronic gastritis | |
CN106728631A (en) | A kind of Chinese medicine preparation for treating hyperpietic with atherosclerosis | |
CN106822852A (en) | Treat pharmaceutical composition, its preparation technology and the purposes of coronary heart disease | |
CN107823231A (en) | The Chinese medicine composition and combination ointment of a kind for the treatment of cancer cervical spondylopathy stomach trouble appendicitis | |
CN101062233A (en) | Powdered medicine for coaptation and its preparing process | |
CN113842422A (en) | Medicine for treating hysteromyoma and preparation method thereof | |
CN1166383C (en) | Medicine for treating tumor in digestive tract and its prepn | |
CN108785614A (en) | It is a kind of to be used to promote Chinese medicine composition of union and preparation method thereof | |
CN114767796A (en) | Composition for erosive gastritis and preparation method thereof | |
CN110227130A (en) | A kind of Chinese medicine composition and preparation method thereof for treating breast cancer | |
CN107823369A (en) | The easypro neck of bone living dissipates | |
CN112972581A (en) | Shenfeng heart-calming composition and preparation method thereof | |
CN101653534B (en) | Coaptation paste | |
CN115814004A (en) | Medicine composition for treating bone disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |